Dem Pharmaceuticals Turkey's mission to be one of the fastest growing pharmaceutical companies since 2016 continues to pursue the installation of production facilities. Dem İlaç production facility is located in Çiftikköy District of Yalova Province on an area of 30 000 m² and has a net closed area of 17 500 m². The pharmaceutical production facility has been designed in accordance with the current GMP (Good Manufacturing Practices) rules for FULLY STERILE medicines and is expected to be operational in September 2020. Biotechnological / nanotechnological pharmaceutical raw material production and vials, ampoules, ready-made injectors, finished product production facility, installation, commissioning qualifications and validations have been completed.

Dem Pharmaceuticals, which has always seen innovative thinking as the most important argument of its strategy of achieving its goals with its innovative approach since its inception, strives to produce ideas that will shape the future of the pharmaceutical world. For this purpose, life is more than just living, it travels with the ideal and gives the necessary value to uninterrupted, innovative solutions.

Dem pharmaceuticals' R&D strategies are structured on developing completely new, innovative pharmaceutical products. He carries out know-how development with a highly experienced R&D team in three different laboratories equipped with high-tech equipment and equipment. Biotechnological pharmaceuticals, Nanotechnological pharmaceuticals, Peptide and Peptide Derivative drug development activities are carried out in our laboratories which are fully equipped for the medical product targeted for development.